1. Airody A., Heath G., Lightman S., Gale R. Non-infectious uveitis: optimising the therapeutic response. Drugs. 2016; 76: 27-39. https://doi.org/10.1007/s40265-015-0502-y.
2. Barry R.G., Nguyen Q.D., Lee R.W. et al. Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol. 2014; 8: 1891-1911. doi: 10.2147/OPTH.S47778.
3. Лисицына Т.А., Алекберова З.С., Давыдова Г.А. и др. Современные представления о терапии увеитов при иммувоспалительных ревматических заболеваниях. Научнопрактическая ревматология. 2020;58 (4): 428-436. doi: 10.47360/1995-4484-2020-428436.
4. Merida S., Palacios E., Amparo N., Bosch-Morell F. New Immunosuppressive Therapies in Uveitis Treatment. Int J Mol Sci. 2015; 16(8): 18778-18795. doi: 10.3390/ijms160818778
5. Панова И.Е., Дроздова Е.А., Авдеева О.Н. Глава 28. Увеиты. В кн.: Офтальмология: национальное руководство / под ред. С.Э. Аветисова, Е.А. Егорова, Л.К. Мошетовой, В.В. Нероева, Х.П. Тахчиди. М.: ГЭОТАР-Медиа, 2018; C. 507-560.
6. Pasadhika S., Rosenbaum J.T. Update on the use of systemic biologic agents in the treatment of noninfectious uveitis. Biologics. 2014; 8:67-81. doi: 10.2147/BTT.S41477.
7. Prete M., Dammacco R., Fatone M.C., Racanelli V. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. Clin Exp Med. 2016; 16(2):125-36. doi: 10.1007/s10238-015-0345-6.
8. de Smet M.D., Taylor S.R., Bodaghi B., et al. Understanding uveitis: the impact of research on visual outcomes. Prog. Retin. Eye Res. 2011; 30(6): 452-470. https://doi.org/10.1016Zj.preteyeres.2011.06.005
9. Lin P., Suhler E.B., Rosenbaum J.T. The future of uveitis treatment. Ophthalmology. 2014; 121: 365-376. https://dx.doi.org/10.1016%2Fj.ophtha.2013.08.029.
10. Agrawal R. Iyer J., Connolly J. et al. Cytokines and biologics in non-infectious autoimmune uveitis: bench to bedside. Indian J Ophthalmol. 2014; 62(1): 74-81. doi: 10.4103/03014738.126187.
11. Boyd S.R., Young S., Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv. Ophthalmol. 2011; 46: 209-233. https://doi.org/10.1016/s0039-6257(01)00275-2.
12. Дроздова Е.А., Теплова С.Н. Роль нарушения процессов регуляции иммунного ответа в патогенезе увеита, ассоциированного с ревматическими заболеваниями. Вестник офтальмологии. 2008; 124 (3): 23-26.
13. Egwuagu C.E., Alhakeem S.A., Mbanefo E.C. Uveitis: molecular pathogenesis and emerging therapies. Front. Immunol. | https://doi.org/10.3389/fimmu.2021.623725
14. Lee R.W.J., Dick A.D. Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation. Eye (Lond); 2012; 26(1):17-28. doi: 10.1038/eye.2011.255.
15. Muhaya M. Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. Clin Exp Immunol. 1999; 16: 410-414. https://dx.doi.org/10.1046%2Fj.1365-2249.1999.00921.x.
16. Acharya N.R., Tham V.M., Esterberg E. et al. Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2013; 131(11): 1405-1412. https://doi.org/10.1001/jamaophthalmol.2013.4237.
17. Durrani O.M., Meads C.A., Murray P.I. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223-36. doi: 10.1159/000078612.
18. Edelsten C, Reddy MA, Stanford MR, Graham EM. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol 2003;135:676-680.
19. Gritz D.C., Wong I.G. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004; 111: 491-500. https://doi.org/10.1016Zj.ophtha.2003.06.014.
20. London N.J., Rathinam S.R., Cunningham E.T. Jr. The epidemiology of uveitis in developing country. Int. Ophthalmol. Clin. 2010; 50(2): 1-17. https://doi.org/10.1097/iio.0b013e3181d2cc6b
21. Miserocchi E., Fogliato G., Modorati G., Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013; 23(5): 705-717. https://doi.org/10.5301/ejo.5000278.
22. Paivonsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand 2000;78:84-88.
23. Siiskonen M., Hirn I., Pesala R. et al. Prevalence, incidence and epidemiology of childhood uveitis. Acta Ophthalmol. 2021; 99(2): e160-e163. https://doi.org/10.1111/aos.14535
24. Конькова А.Ю., Гаврилова Т.В., Черешнева М.В. Состояние заболеваемости увеитами в Пермском крае. Вестник Совета молодых ученых и специалистов Челябинской области. 2015; 4(11), T2: 31-35.
25. Shin Y., Kang Ji-M., Junwon Lee et al. Epidemiology of pediatric uveitis and associated systemic diseases. Pediatric Rheumatology 2021; 19: 48. https://doi.org/10.1186/s12969-021-00516-2
26. Smith J.A., Mackensen F., Sen H.N. et al., Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116(8):1544-51, doi: 10.1016/j.ophtha.2009.05.002.
27. BenEzra D, Cohen E, Maftzir G Uveitis in children and adolescents Br J Ophthalmol. 2005 Apr;89(4):444-8. doi: 10.1136/bjo.2004.050609.
28. de Boer J., Wulffraat N., Rothova A. Visual loss in uveitis of childhood Br J Ophthalmol. 2003;87(7):879-84. doi: 10.1136/bjo.87.7.879.
29. Heiligenhaus A., Niewerth M., Ganser G. et al. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population based nation white study in Germany: suggested modification of the current screening guidelines. Rheumatology. 2007; V. 46. P. 1015-19.
30. Kotaniemi K., Kautiainen H., Karma A., Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology. 2001; V. 108 (11): Р. 2071 -75.
31. Rothova A., Suttorp-van Schulten M.S., Frits Treffers W., et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br. J. Ophthalmol. 1996; 80(4): 332-336. https://dx.doi.org/10.1136%2Fbjo.80.4.332.